Diffuse Alveolar Hemorrhage in Hematopoietic Cell Transplantation

Area of Science:

• Hematology
• Pulmonology
• Critical Care Medicine

Background:

• Diffuse alveolar hemorrhage (DAH) is a life-threatening syndrome following hematopoietic cell transplantation (HCT).
• It typically presents with acute respiratory failure within weeks of HCT, mimicking pneumonia.
• Diagnosis relies on excluding infection and identifying bloody bronchoalveolar lavage fluid.

Purpose of the Study:

• To review the diagnosis and management of DAH post-HCT.
• To discuss the underlying pathophysiology and potential future therapies.

Main Methods:

• Review of existing literature on DAH in HCT recipients.
• Analysis of diagnostic criteria and treatment modalities.
• Discussion of etiological factors and emerging therapeutic targets.

Main Results:

• DAH presents with alveolar filling on imaging and respiratory distress.
• Causes are multifactorial, including conditioning regimens, GVHD, and medications.
• Current treatments include supportive care, corticosteroids, and transfusions, with limited efficacy.

Conclusions:

• DAH post-HCT is a significant cause of morbidity and mortality.
• Improved understanding of pathophysiology is needed for novel therapeutic strategies.
• Further research into targeted therapies is essential for improving outcomes.